MEDNAX, INC. (NYSE:MD) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k
-
0

MEDNAX, INC. (NYSE:MD) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.

On May16, 2018, MEDNAX, Inc., a Florida corporation (the “Company”), held its 2018 Annual Shareholders’ Meeting (the “Annual Meeting”). Of the 94,382,958 shares of common stock outstanding and entitled to vote,80,104,963 shares were represented, constituting a quorum.The final results for each of the matters submitted to a vote of shareholders at the Annual Meeting are as follows:

Proposal 1: All of the Board’s nominees for Director were elected to serve until the Company’s 2019 Annual Shareholders’ Meeting or until their respective successors are elected and qualified, by the votes set forth in the table below:

Name

 For Withheld Broker Non-Vote

Cesar L. Alvarez

 60,414,183 14,875,864 4,814,916

Karey D. Barker

 65,474,986 9,815,061 4,814,916

Waldemar A. Carlo, M.D.

 57,711,214 17,578,833 4,814,916

Michael B. Fernandez

 58,687,051 16,602,996 4,814,916

Paul G. Gabos

 63,762,666 11,527,381 4,814,916

Pascal J. Goldschmidt, M.D.

 64,145,112 11,144,935 4,814,916

Manuel Kadre

 61,273,031 14,017,016 4,814,916

Roger J. Medel, M.D.

 64,230,027 11,060,020 4,814,916

Enrique J. Sosa, Ph.D.

 63,042,327 12,247,720 4,814,916

Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2018 fiscal year was ratified by the shareholders, by the votes set forth in the table below:

For

Against

Abstained

Broker

Non-Vote

77,993,626

 2,095,031 16,306

Proposal 3: The shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, by the votes set forth in the table below:

For

Against

Abstained

Broker

Non-Vote

55,498,607

 19,671,689 119,751 4,814,916


About MEDNAX, INC. (NYSE:MD)

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. Its physician specialties and services include neonatal care, anesthesia and anesthesia subspecialty care, pain management, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. It also offers revenue cycle management and consulting services.